Which has grown faster, AXGN or BCRX?

Over the past five years, BCRX grew revenue faster — AXGN at a 13.99% CAGR versus BCRX at 64.07%.

How have AXGN and BCRX total returns compared?

Over the past 10 years, AXGN delivered 15.98% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

AxoGen, Inc. (AXGN) vs BioCryst Pharmaceuticals, Inc. (BCRX)

A side-by-side comparison of AxoGen, Inc. and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AXGN

AxoGen, Inc.

$2.00B

$37.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BCRX

BioCryst Pharmaceuticals, Inc.

$2.06B

$8.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — AXGN vs BCRX

growth of $100 · dividends reinvested · last 10y

AXGN +326.8% (+15.6%/yr)BCRX +100.5% (+7.2%/yr)AXGN compounded faster over this window

AXGN BCRX

AXGN vs BCRX: by the numbers

•BCRX is the larger company ($2.06B vs $2.00B market cap).
•Both run net losses; AXGN's is the smaller (-13.36% vs -40.90% net margin).
•BCRX grew revenue faster over the past five years (64.07% vs 13.99% CAGR).

Metrics side by side

Valuation

Metric	AXGN	BCRX
Forward P/E	84.11	N/A
P/S ratio	7.97	2.19
P/B ratio	7.81	N/A
FCF yield	0.13%	17.35%

Profitability

Metric	AXGN	BCRX
Gross margin	74.56%	97.82%
Operating margin	-5.12%	38.98%
Net margin	-13.36%	-40.90%
ROE	-13.09%	N/A
ROIC	-4.68%	-89.73%

Growth (annualized)

Metric	AXGN	BCRX
Revenue CAGR (5Y)	13.99%	64.07%
Total return CAGR (5Y)	19.40%	-10.02%

Frequently asked

Which has grown faster, AXGN or BCRX?: Over the past five years, BCRX grew revenue faster — AXGN at a 13.99% CAGR versus BCRX at 64.07%.
How have AXGN and BCRX total returns compared?: Over the past 10 years, AXGN delivered 15.98% and BCRX delivered 5.82% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AXGN analysis Full BCRX analysis Interactive comparison tool

Dig into the metrics

AxoGen ROE BioCryst Pharmaceuticals ROE AxoGen operating margin BioCryst Pharmaceuticals operating margin AxoGen revenue growth BioCryst Pharmaceuticals revenue growth AxoGen free cash flow BioCryst Pharmaceuticals free cash flow

AxoGen & BioCryst Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.